LENSKARTLenskart Solutions Limited
Healthcare · Medical Instruments & Supplies · NSE · as of 2026-10-26 (delayed ~30 min in market hours)
Lenskart Solutions Limited, a technology-driven eyewear company, engages in designing, manufacturing, branding, and retailing of eyewear products in India, Japan, Southeast Asia, and the Middle East. The company's products include prescription eyeglasses, sunglasses, goggles, screen glasses, and other products, such as contact lenses and eyewear accessories, including frames for men, women, and kids. It engages in lens manufacturing, lens edging, lens design, frame design, frame manufacturing, and delivery. The company operates as a direct-to-consumer company that designs and sells a wide range of eyewear products under the Lenskart and Owndays brands; and sub brands, including John Jacobs, Vincent Chase, Hooper, Lenskart Air, and Hustlr. It sells its products through online and offline channels, such as retail stores, websites, mobile applications, and other channels. The company also owns and operates eyewear retail stores in India and provides home eye check-up services. Lenskart Solutions Limited was incorporated in 2008 and is based in Gurugram, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on LENSKART — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
The picture
- • Revenue growth: 45.6% YoY
- • Debt/Equity: 0.35
- • Price vs SMA200: above
- • Golden cross setup: SMA50 above SMA200
- • Trend strength (ADX): 31
- • 3-month return: +17.4%
Bull case
- • Revenue growth: 45.6% YoY
- • Debt/Equity: 0.35
- • Price vs SMA200: above
- • Golden cross setup: SMA50 above SMA200
Bear case
- • Profit growth: -10.8% YoY
- • ROE: 6.7%
- • MACD: bearish
- • Price vs EMA21: below
Key risks
- • Weak fundamentals — technical strength may not sustain
- • Profit growth: -10.8% YoY
- • ROE: 6.7%
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹20.98). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.